Top 20 of Glomerulonephritis, Membranous

Article title # Publications/# Citations

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

2009: DMBeck; LHBeck; RGBonegio; TDCummins; JBKlein; GLambeau; DWPowell; DJSalant;

113

The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.

1999: LBarisoni; VD'Agati; WKriz; PMundel;

89

Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

2000: AAcharya; JNeugarten; SRSilbiger;

65

Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

2011: MArcos-Burgos; DBacq-Daian; DBockenhauer; PBrenchley; MJCoenen; HDebiec; Mden Heijer; LDragomirescu; ... JFeehally; JMHofstra; MHubank; LAKiemeney; RKleta; AKöttgen; VLaundy; PWMathieson; AMedlar; SPadmanabhan; NPatel; KPearce; SHPowis; AJRees; PRonco; HCStanescu; BStengel; HAStephens; CVoinescu; JFWetzels; AZawadzka;

42

Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction.

1957: HRHolman; RCMellors; LGOrtega;

42

Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis.

2001: NAptsiauri; GSHageman; RFMullins;

39

Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.

2002: ABensman; HDebiec; FDecobert; GDeschênes; VGuigonis; JPHaymann; BMougenot; PMRonco;

33

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

2011: DMBeck; LHBeck; RGBonegio; DCCattran; FGCosio; SBErickson; FCFervenza; FAMalik; DJSalant;

32

The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development.

2005: PFCheng; SMCowley; RNEisenman; BMIritani; HDLiggitt; SMMendrysa; TXu; JYada;

32

Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

2001: LBiancone; GCamussi; PGConaldi; SDoublier; ELupia; PReponen; VRuotsalainen; GSalvidio; KTryggvason;

31

Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells.

2006: YTHuang; YHKuo; CLLin; KSurendran; FSWang; JYWang;

31

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

2011: DMBeck; LHBeck; JMHofstra; DJSalant; JFWetzels;

28

Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy.

2005: DGBrownstein; SHCross; IJJackson; AWLee; LMcKie; JJMullins; EPöschl; YSado; USchlötzer-Schrehardt; TVan Agtmael;

27

Urine biomarkers predict the cause of glomerular disease.

2007: JSAlmeida; JMArthur; MNBudisavljevic; JCOates; TBPowell; JRRaymond; SAVarghese;

27

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

2010: LAllegri; MBruschi; GCandiano; MLCarnevali; ECorradini; RGatti; GMGhiggeri; PKador; ... AMagnasco; SMattei; CMurtas; APetretto; MPrunotto; LSantucci; FScolari; ATrivelli;

26

Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.

2000: CEAlpers; VD'Agati; FEitner; TGoodpaster; KLHudkins; SJShankland;

26

Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.

2003: CDCohen; KFrach; HJGröne; AHenger; MKretzler; DSchlondorff; HSchmid;

26

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

2007: FGCosio; SDeGoey; JMGloor; MDGriffin; TSLarson; SBMoore; WDPark; SSethi; MDStegall;

26

Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.

2005: JFloege; HHaller; MHaubitz; HMischak; HDRupprecht; MWalden; EMWeissinger; SWittke;

26

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry.

2004: ABurchard; TKaiser; WKolch; RKrebs; HMischak; NVNeuhoff; APitt; BSchlegelberger; ASundmacher; SWittke;

25